Previous View
 
APSnet Home
 
MPMI Home


VIEW ARTICLE   |    DOI: 10.1094/MPMI-8-0058


Transgenic Tobacco Plants Expressinga Truncated Form of the PAMV Capsid Protein (CP)Gene Show CP-Mediated Resistanceto Potato Aucuba Mosaic Virus. D. Leclerc. Department of Botany, University of Toronto, 25 Willcocks St., Toronto, Ontario, Canada M5S 3B2. M. G. AbouHaidar. Department of Botany, University of Toronto, 25 Willcocks St., Toronto, Ontario, Canada M5S 3B2. MPMI 8:58-65. Accepted 24 October 1994. Copyright 1995 The American Phytopathological Society.


Four constructs of the potato aucuba mosaic virus (PAMV) coat protein (CP) gene were engineered for expression in tobacco plants: The full-length CP sequence (FL CP), two truncated forms-one at (he N terminus (46 amino acid residues are deleted) (NT138), one in the conserved core portion (86 amino acids deleted) (CT258) of the gene-and an antisense RNA construct. These constructs were introduced into tobacco plants (Nicotiana tabacum) via Agrobaclerium tumefaciens-mediated transformation. The plants transformed with the NT138 and FL CP constructs produced the mRNAs and proteins from the respective transgene. Transformants with the CT258 construct produced the transgenic mRNA, but the modified CP was not delected in the 20 different transformants tested. Transgenic R0 and R1 tobacco plants expressing the full-length, CT258, and the antisense constructs exhibited protection to PAMV infection and a delay in symptom development when inoculated with 0.1 and 0.5 (g/ml of purified PAMV. Transgenic plants expressing the NT138 construct did not confer any detectable protection to PAMV infection. These results suggest that an engineered coat protein mediated resistance (CPMR) can be obtained from a CP gene truncated in its core region. The role of the N-terminal domain or the CP in the CPMR of PAMV and the implication of either the RNA or the protein in the protection is discussed.

Additional Keywords: genetically engineered cross-protection.